Typical monthly costs for medicines and testing supplies to control diabetes, for two common categories of patients who don't have other health problems. Prices are the full cost, and would be lower for someone with insurance. At bottom are initial costs for hospitalized patients with common complications from cutting back on care:
Typical patient with Type 1, or insulin-dependent, diabetes:
Humalog fast-acting insulin: $104.11
Lantus long-acting insulin: $77.20
1 syringe/day for Lantus: $10.50
3 pen needles/day for Humalog: $33.64
4 lancets/day (for finger pricking): $14.99
4 test strips/day: $123.59
Accupril (prevents kidney damage): $58.77
———
Total: $422.80
Typical patient with Type 2 diabetes:
Glucotrol XL (helps body make more insulin): $70.33
metformin (helps control blood sugar): $4
Actos (reduces insulin resistance): $222.38
1 lancet/day: $3.75
1 test strip/day: $30.90
———
Total: $331.36
Average hospitalization for Type 2 diabetes patient who develops a life-threatening complication called ketoacidosis:
$11,080
Average hospitalization for Type 2 diabetes patient who develops dangerously high blood sugar:
$6,430
———
Sources: American Diabetes Association, www.drugstore.com, U.S. Agency for Healthcare Research and Quality
- KSL-TV welcomes 2 new anchors, new format
- Selling adventure: How Backcountry.com's CEO...
- Couple can't retire because of $116,000 in...
- Studies try to find why poorer people are...
- West Jordan teen releases 5th iPhone app
- On Leadership: Highly engaged employees look...
- KSL TV news icon Bruce Lindsay calls it a career
- Flying with your children just got more...
- Studies try to find why poorer people...
27 - KSL-TV welcomes 2 new anchors, new format
17 - Couple can't retire because of $116,000...
15 - Millennials love to spend money they...
14 - House GOP plans summer tax cut vote
7 - Consumer confidence highest in 4½...
6 - Self consumption is considered greedy,...
2 - Typical CEO made $9.6M last year, AP...
1






DeseretNews.com encourages a civil dialogue among its readers. We welcome your thoughtful comments.
— About comments